semaglutide peptides research GLP-1 Receptor Agonist Reference Semaglutide Research Peptide: GLP-1R Scientific

Some of the most common or potential side effects include: Nausea Constipation Vomiting Diarrhea Abdominal Pain Headache Indigestion Dizziness Back pain Increased Lipase or Amylase Altered taste Nasopharyngitis (common cold) Passing Gas Bloating Belching Gastroenteritis Decreased appetite Fatigue Gastroesophageal reflux disease Low blood sugar (hypoglycemia) in those with Type 2 diabetes Upset stomach These symptoms often subside as your body adjusts to the medications

Around 3,800 participants were enrolled across both trials, randomized to placebo or oral semaglutide 14 mg daily for up to 104 weeks (~2 years)

Fatigue accompanies concerning symptoms like chest pain, severe shortness of breath, fainting episodes, confusion, or other neurological changes

The goal

Semaglutide GLP-1 is typically administered once a week, either via subcutaneous injection or a pre-filled pen